Selected Publications:
Whitney JB, Hill AL, Sanisetty S, Penaloza-MacMaster, Liu J, Shetty M, Parenteau L, Cabral C, Shields J, Blackmore S, Smith JY, Brinkman AL, Peter LE, Mathew SI, Smith KM, Borducchi EN, Rosenbloom DIS, Lewis MG, Hattersley J, Li B, Hesselgesser J, Geleziunas R, Robb ML, Kim JH, Michael NL, Barouch DH. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 2014.
Penaloza-MacMaster P, Kamphorst AO, Wieland A, Araki K , Iyer SS, West EE, O'Mara L, Yang S, Konieczny BT, Sharpe AH, Freeman GJ, Rudensky AY, Ahmed R. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. The Journal of Experimental Medicine, 2014.
Penaloza-MacMaster P, Barber DL, Wherry EJ, Provine NM, Teigler JE, Parenteau L, Blackmore S, Borducchi EN, Larocca RA, Yates K, Shen H, Haining WN, Sommerstein R, Pinschewer DD, Ahmed R, Barouch DH. Immunopathology of vaccine-elicited CD4 T cells following chronic LCMV infection. Science, 2015.
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection. Yidan Wang, Young Rock Chung, Simon Eitzinger, Nicole Palacio, Shana Gregory, Mitra Bhattacharyya, Penaloza-MacMaster, P. PLOS Pathogens, 2019.
IFN-I blockade improves the efficacy of viral vaccines. Nicole Palacio, Tanushree Dangi, Young Rock Chung, Yidan Wang, Juan Luis Loredo, Zhongyao Zhang, Pablo Penaloza-MacMaster. The Journal of Experimental Medicine, 2020.
Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. Tanushree Dangi, Jacob Class, Nicole Palacio, Justin Richner, Pablo Penaloza-MacMaster. Cell Reports, 2021.
Fractionating Ad5-vectored SIV and SARS-CoV-2 vaccines improves virus-specific immunity. Sarah Sanchez, Nicole Palacio, Tanushree Dangi, Thomas Ciucci, Pablo Penaloza-MacMaster. Science Immunology, 2021.
Cross-protective immunity following coronavirus vaccination and coronavirus infection. Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Jacob Class, Lavanya Visvabharathy, Thomas Ciucci, Igor Koralnik, Justin Richner, Pablo Penaloza-MacMaster. The Journal of Clinical Investigation, 2021.
A Nucleocapsid-specific monoclonal antibody improves the control of SARS-CoV-2. Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle Richner, Lavanya Visvabharathy, Igor J. Koralnik, Justin M. Richner, Pablo Penaloza-MacMaster. The Journal of Clinical Investigation, 2022.
Pre-existing immunity modulates responses to mRNA boosters. Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Lavanya Visvabharathy, Justin Richner, Igor Koralnik, Pablo Penaloza-MacMaster. Cell Reports, 2023.
SARS-CoV-2 Bottlenecks and Tissue-Specific Adaptation in the Central Nervous System. Justin Richner, Jacob Class , Lacy Simons, Ramon Lorenzo-Redondo, Laura Cooper, Tanushree Dangi , Pablo Penaloza-MacMaster, Egon Ozer , Lijun Rong, Judd Hultquist. Nature Microbiology, 2024.
An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-I. Young Rock Chung, Bakare Awakoaiye, Tanushree Dangi, Slim Fourati, Pablo Penaloza-MacMaster. The Journal of Clinical Investigation, 2024.
Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice. Sarah Sanchez, Tanushree Dangi, Slim Fourati , Pablo Penaloza-MacMaster. The Journal of Clinical Investigation, 2024.
Complete list of publications: https://pubmed.ncbi.nlm.nih.gov/?term=pablo+penaloza-macmaster&sort=date